MISSION VIEJO, Calif., June 20, 2026
Kyowa Hakko USA has unveiled promising new research demonstrating the potential acute cognitive benefits of Cognizin® Citicoline, a clinically studied brain health ingredient, following a single dose in healthy adults. The findings, scheduled for presentation at the 2026 International Society of Sports Nutrition (ISSN) Annual Conference, provide new evidence that Cognizin may support brain activity, focus, attention, and cognitive performance within hours of consumption. The randomized, double-blind, placebo-controlled crossover study explored the effects of a single 500 mg dose of Cognizin® Citicoline, evaluating participants through electroencephalogram (EEG) brain wave monitoring, cognitive performance assessments, and subjective mood evaluations. While Cognizin has long been recognized for supporting cognitive health through long-term supplementation, the new proof-of-concept study suggests that measurable neurological and cognitive benefits may begin much sooner than previously understood. The findings further strengthen the scientific foundation supporting Cognizin’s role in the rapidly expanding cognitive health and functional nutrition sectors.
Single-Dose Study Demonstrates Changes in Brain Activity
The study focused on healthy adult males and investigated how a single administration of Cognizin influenced neuroelectric activity and cognitive function over a short period. Researchers conducted assessments at both 60 minutes and 240 minutes post-ingestion, enabling evaluation of both immediate and sustained responses. Advanced EEG analysis was used to measure brain wave activity while validated cognitive testing examined attention, focus, processing speed, and mental performance. Investigators also assessed mood and affect to better understand the broader neurological impact of supplementation.
The findings indicate that Cognizin may influence brain function through measurable changes in neural activity shortly after administration, supporting the hypothesis that citicoline supplementation can rapidly enhance cognitive performance. These results add a new dimension to existing research demonstrating the ingredient’s effectiveness in supporting memory, concentration, and mental energy through longer-term use.
Expanding Opportunities in Cognitive Health Innovation
Advertisement
Cognitive health continues to be one of the fastest-growing segments within the nutritional science, functional food, and wellness industries. Consumers increasingly seek evidence-based solutions that support productivity, focus, mental resilience, and healthy aging. As demand grows, ingredient manufacturers are under pressure to demonstrate clinical efficacy through rigorous scientific research. The latest Cognizin study represents an important step toward understanding the acute mechanisms through which citicoline may support cognitive performance.
Researchers believe that identifying rapid-onset cognitive benefits could have important implications for product development across multiple categories, including sports nutrition, functional beverages, nootropic supplements, healthy aging products, and cognitive performance formulations. The study also highlights the value of integrating objective neurophysiological measurements such as EEG analysis into future cognitive health research, helping provide deeper insight into how nutritional interventions influence brain function.
Clinical Science Strengthens Cognizin’s Market Position
Developed by Kyowa Hakko Bio Co., Ltd., Cognizin® Citicoline remains one of the most extensively researched ingredients in the cognitive health category, supported by more than three decades of scientific investigation. The ingredient has been clinically evaluated for its ability to support memory, focus, attention, concentration, mental energy, and overall brain health, making it a widely recognized component in premium cognitive wellness formulations. The latest proof-of-concept findings reinforce Kyowa Hakko’s ongoing commitment to evidence-based innovation and clinical validation. As the cognitive health market becomes increasingly competitive, studies demonstrating both acute and long-term benefits may serve as important differentiators for ingredient developers and brand owners.
By continuing to expand the scientific understanding of citicoline’s neurological effects, Kyowa Hakko aims to support the development of next-generation cognitive health solutions that address growing consumer demand for scientifically substantiated wellness products. The research also contributes to broader efforts aimed at understanding how nutritional interventions can optimize brain performance and support cognitive well-being throughout life.
Source: Kyowa Hakko USA, Cognizin press release
